User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 17 results.
    • Journal article
    Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
    Curigliano, Giuseppe Banerjee, Susana Cervantes, Andrés Garassino, Marina C Garrido, Pilar Girard, Nicolas Haanen, John Jordan, Karin Lordick, Florian Machiels, Jean-Pascal[UCL] Michielin, Olivier Peters, Solange Tabernero, Josep Douillard, Jean-Yves Pentheroudakis, George Panel members (2020) Annals of oncology — Vol. 31, no. 10, p. 1320-1335 (2020)
    • Speech
    Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
    Tabernero, Josep Van Cutsem, Eric Díaz-Rubio, Eduardo Cervantes, Andrés Humblet, Yves[UCL] Andre, Thierry Van Laethem, Jean-Luc Soulie, Patrick Casado, Esther Verslype, Chris Valera, Javier Sastre Tortora, Giampaolo Ciardiello, Fortunato Kisker, Oliver de Gramont, Aimery (2007) The American Society of Clinical Oncology Gastrointestinal Symposium — Orlando(Fl)
    • Speech
    Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS.
    Mansoor, Wasat Arkenau, Hendrik-Tobias ALSINA, MARIA Shitara, Kohei Tejani, Mohamedtaki Abdulaziz Thuss-Patience, Peter C. Cuffe, Sinead Dvorkin, Mikhail Park, David Ando, Takayuki Van den Eynde, Marc[UCL] Beretta, Giordano D. Zaniboni, Alberto Doi, Toshihiko Tabernero, Josep Ilson, David H. Makris, Lukas McGuigan, Sandra Van Cutsem, Eric (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (NONCOLORECTAL) CANCER —
    • Journal article
    Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
    Dasari, Arvind Lonardi, Sara Garcia-Carbonero, Rocio Elez, Elena Yoshino, Takayuki Sobrero, Alberto Yao, James García-Alfonso, Pilar Kocsis, Judit Cubillo Gracian, Antonio Sartore-Bianchi, Andrea Satoh, Taroh Randrian, Violaine Tomasek, Jiri Chong, Geoff Paulson, Andrew Scott Masuishi, Toshiki Jones, Jeremy Csőszi, Tibor Cremolini, Chiara Ghiringhelli, Francois Shergill, Ardaman Hochster, Howard S Krauss, John Bassam, Ali Ducreux, Michel Elme, Anneli Faugeras, Laurence[UCL] Kasper, Stefan Van Cutsem, Eric Arnold, Dirk Nanda, Shivani Yang, Zhao Schelman, William R Kania, Marek Tabernero, Josep Eng, Cathy FRESCO-2 Study Investigators (2023) Lancet (London, England) — Vol. 401, no. 10395, p. 41-53 (2023)
    • Journal article
    Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
    Tabernero, Josep Yoshino, Takayuki Cohn, Allen Lee Obermannova, Radka Bodoky, Gyorgy Garcia-Carbonero, Rocio Ciuleanu, Tudor-Eliade Portnoy, David C Van Cutsem, Eric Grothey, Axel Prausová, Jana Garcia-Alfonso, Pilar Yamazaki, Kentaro Clingan, Philip R Lonardi, Sara Kim, Tae Won Simms, Lorinda Chang, Shao-Chun Nasroulah, Federico RAISE Study Investigators Van den Eynde, Marc[UCL] Humblet, Yves[UCL] (2015) The Lancet Oncology — Vol. 16, p. 499-508 (2015)
    • Journal article
    Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.
    Emile, Jean-François Julié, Catherine Le Malicot, Karine Lepage, Come Tabernero, Josep Mini, Enrico Folprecht, Gunnar Van Laethem, Jean-Luc Dimet, Stéphanie Boulagnon-Rombi, Camille Allard, Marc-Antoine Penault-Llorca, Frédérique Bennouna, Jaafar Laurent-Puig, Pierre Taieb, Julien PETACC8 Study Investigators Austrian Breast and Colorectal cancer Study Group (ABCSG) Belgian Group of Digestive Oncology (BGDO) Lone Nørgård Petersen Fédération Francophone de Cancérologie Digestive (FFCD) Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) Fédération Nationale des Centres de Lutte Contre le Cancer Association Européenne de Recherche en Oncologie (AERO) Arbeitsgemeinschaft Internistische Onkologie (AIO) Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD) Gruppo Oncologico dell'Italia Meridionale (GOIM) Istituto Oncologico Romagnolo (IOR) Gruppo Cooperativo Chirurgico Italiano (GOCCI) Gruppo Oncologico Nord Ovest (GONO) Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) Gruppo Cooperativo do Cancro Digestivo da Associação Portuguesa de Investigação Oncológica (GCCD, APIO) Grupo Español para el Tratamiento de los Tumores Digestivos (TTD) John Allen Bridgewater Kerger, Joseph[UCL] Humblet, Yves[UCL] (2017) European Journal of Cancer — Vol. 82, p. 16-24 (2017)
    • Journal article
    Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy
    Van Cutsem, Eric Joulain, Florence Hoff, Paulo M Mitchell, Edith Ruff, Paul Lakomý, Radek Prausová, Jana Moiseyenko, Vladimir M van Hazel, Guy Cunningham, David Arnold, Dirk Schmoll, Hans-Joachim Ten Tije, Albert J McKendrick, Joseph Kröning, Hendrik Humblet, Yves[UCL] Grávalos, Cristina Le-Guennec, Solenn Andria, Michael Dochy, Emmanuelle Vishwanath, Raghu L Macarulla, Teresa Tabernero, Josep (2016) Targeted Oncology : biotherapies for the clinicians in oncology — Vol. 11, no. 3, p. 383-400 (2016)
    • Journal article
    Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
    Pant, Shubham Schuler, Martin Iyer, Gopa Witt, Olaf Doi, Toshihiko Qin, Shukui Tabernero, Josep Reardon, David A Massard, Christophe Minchom, Anna Lugowska, Iwona Carranza, Omar Arnold, Dirk Gutierrez, Martin Winter, Helen Stuyckens, Kim Crow, Lauren Najmi, Saltanat Hammond, Constance Thomas, Shibu Santiago-Walker, Ademi Triantos, Spyros Sweiti, Hussein Loriot, Yohann Carranza, Omar Greco, Martin Alberto Coward, Jim Joshua, Anthony Karapetis, Christos Hart, Christopher Zhang, Alison Prenen, Hans Goeminne, Jean-Charles Machiels, Jean-Pascal[UCL] Rottey, Sylvie Corassa, Marcelo Molin, Graziela Zibetti Dal Tiscoski, Katsuki Jardim, Denis Leonardo Fontes Mak, Milena Fu, Wei Yao, Herui Huang, Jing Jiang, Haiping Qin, Shukui Chen, Baoshi Yan, Dong Yang, Yu Loriot, Yohann Le Tourneau, Christophe Penel, Nicolas Salas, Sébastien Blay, Jean-Yves Brachet, Pierre-Emmanuel Durando, Xavier Emambux, Sheik Ravaud, Alain Folprecht, Gunnar Arnold, Dirk Schuler, Martin Ahrens, Marit Golf, Alexander Haag, Georg Martin Lordick, Florian Desuki, Alexander Cazzaniga, Marina Ciardiello, Fortunato Milella, Michele Koyama, Takafumi Hirooka, Yoshiki Okamoto, Wataru Aogi, Kenjiro Kuboki, Yasutoshi Lee, Jungyun Kim, Sung-Bae Ahn, Myung-Ju Chang, Jong Hee Kim, Yong-Man Nam, Do-Hyun Park, Jae-Sung Lugowska, Iwona Paz-Ares, Luis Moreno, Victor Cervantes, Andres Calvo, Mariona Falcon, Alejandro Gonzalez, Antonio Tabernero, Josep Martinez Bueno, Alejandro García-Corbacho, Javier Longo, Federico Yen, Chia-Jui Chen, Jen-Shi Hou, Ming-Feng Chao, Yee Rau, Kun-Ming Chiu, Tai-Jan Feng, Yin-Hsun Hsu, Chih-Hung Huang, Wen-Tsung Lai, Kuan-Ming Yeh, Su-peng Palmer, Daniel Minchom, Anna Winter, Helen Welsh, Liam Plummer, Ruth Iyer, Gopakumar Gutierrez, Martin Bilen, Mehmet Arrowsmith, Edward Pant, Shubham Spigel, David Robert Zandberg, Dan Paul Doroshow, Deborah Lu-Emerson, Christine Moezi, Mehdi Paulson, Scott Reardon, David Ward, Patrick Chaves, Jorge Grigg, Claud Hussein, Atif Manda, Sudhir Monticelli, Michael Qamar, Rubina Richey, Stephen L Tamura, David Wilks, Sharon (2023) The Lancet Oncology — Vol. 24, no.8, p. 925-935 (2023)
    • Journal article
    Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
    Mansoor, Wasat Arkenau, Hendrik-Tobias Alsina, Maria Shitara, Kohei Thuss-Patience, Peter Cuffe, Sinead Dvorkin, Mikhail Park, David Ando, Takayuki Van den Eynde, Marc[UCL] Beretta, Giordano D Zaniboni, Alberto Doi, Toshihiko Tabernero, Josep Ilson, David H Makris, Lukas Benhadji, Karim A Van Cutsem, Eric (2021) Gastric cancer — Vol. 24, no. 4, p. 970-977 (2021)
    • Journal article
    Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT).
    Marabelle, Aurélien Andtbacka, Robert Harrington, Kevein Melero, Ignacio Leidner, Rom de Baere, Thierry Robert, Caroline Ascierto, Paolo A Baurain, Jean-François[UCL] Imperiale, Michael Rahimian, Shah Tersago, Dominique Klumper, Edwin Hendriks, Maaike Kumar, Rakesh Stern, Martin Öhrling, Katarina Massacesi, Cristian Tchakov, Ilian Tse, Archie Douillard, Jean-Yves Tabernero, Josep Haanen, John Brody, Joshua (2018) Annals of Oncology — Vol. 29, no.11, p. 2163-2174 (2018)
    • Journal article
    Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).
    Ricotta, Riccardo Verrioli, Antonella Ghezzi, Silvia Porcu, Luca Grothey, A Falcone, Alfredo Van Cutsem, Eric Argilés, Guillem Adenis, Antoine Ychou, Marc Barone, Carlo Bouché, Olivier Peeters, Marc Humblet, Yves[UCL] Mineur, Laurent Sobrero, Alberto F Hubbard, Joleen M Cremolini, Chiara Prenen, Hans Tabernero, Josep Jarraya, Hajer Mazard, Thibault Deguelte-Lardiere, Sophie Papadimitriou, Konstantinos Van den Eynde, Marc[UCL] Pastorino, Alessandro Redaelli, Daniela Bencardino, Katia Funaioli, Chiara Amatu, Alessio Carlo-Stella, Giulia Torri, Valter Sartore-Bianchi, Andrea Vanzulli, Angelo Siena, Salvatore (2017) ESMO Open — Vol. 1, no. 6, p. e000111 [1-10] (2017)
    • Journal article
    Combined BRAF, EGFR, and MEK Inhibition in Patients with -Mutant Colorectal Cancer.
    Corcoran, Ryan B André, Thierry Atreya, Chloe E Schellens, Jan H M Yoshino, Takayuki Bendell, Johanna C Hollebecque, Antoine McRee, Autumn J Siena, Salvatore Middleton, Gary Muro, Kei Gordon, Michael S Tabernero, Josep Yaeger, Rona O'Dwyer, Peter J Humblet, Yves[UCL] De Vos, Filip Jung, A Scott Brase, Jan C Jaeger, Savina Bettinger, Severine Mookerjee, Bijoyesh Rangwala, Fatima Van Cutsem, Eric (2018) Cancer discovery — Vol. 8, no.4, p. 428-443 (2018)
    • Journal article
    Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer
    Douillard, Jean-Yves Oliner, Kelly S Siena, Salvatore Tabernero, Josep Burkes, Ronald Barugel, Mario Humblet, Yves[UCL] Bodoky, Gyorgy Cunningham, David Jassem, Jacek Rivera, Fernando Kocákova, Ilona Ruff, Paul Błasińska-Morawiec, Maria Šmakal, Martin Canon, Jean Luc Rother, Mark Williams, Richard Rong, Alan Wiezorek, Jeffrey Sidhu, Roger Patterson, Scott D (2013) New England Journal of Medicine — Vol. 369, no.11, p. 1023-1034 (2013)
    • Journal article
    A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors
    Angevin, Eric Tabernero, Josep Elez, Elena Cohen, Steven J Bahleda, Rastilav van Laethem, Jean-Luc Ottensmeier, Christian Lopez-Martin, Jose A Clive, Sally Joly, Florence Ray-Coquard, Isabelle Dirix, Luc Machiels, Jean-Pascal[UCL] Steven, Neil Reddy, Manjula Hall, Brett Puchalski, Thomas A Bandekar, Rajesh van de Velde, Helgi Tromp, Brenda Vermeulen, Jessica Kurzrock, Razelle (2014) Clinical Cancer Research — Vol. 20, no.8, p. 2192-2204 (2014)
    • Journal article
    Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
    Grothey, Axel Van Cutsem, Eric Sobrero, Alberto Siena, Salvatore Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Tabernero, Josep Yoshino, Takayuki Lenz, Heinz-Josef Goldberg, Richard M Sargent, Daniel J Cihon, Frank Cupit, Lisa Wagner, Andrea Laurent, Dirk CORRECT Study Group (2013) The Lancet — Vol. 381, no.9863, p. 303-12 (2013)
    • Journal article
    Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer : the PRIME study
    Douillard, Jean-Yves Siena, Salvatore Cassidy, James Tabernero, Josep Burkes, Ronald Barugel, Mario Humblet, Yves[UCL] Bodoky, György Cunningham, David Jassem, Jacek Rivera, Fernando Kocákova, Ilona Ruff, Paul Błasińska-Morawiec, Maria Šmakal, Martin Canon, Jean-Luc Rother, Mark Oliner, Kelly S Wolf, Michael Gansert, Jennifer (2010) Journal of Clinical Oncology — Vol. 28, no. 31, p. 4697-4705 (2010)
    • Journal article
    Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial
    Tabernero, Josep Lenz, Heinz-Josef Siena, Salvatore Sobrero, Alberto Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Yoshino, Takayuki Goldberg, Richard M. Sargent, Daniel J. Wagner, Andrea Laurent, Dirk Teufel, Michael Jeffers, Michael Grothey, Axel Van Cutsem, Eric (2015) The Lancet Oncology — Vol. 16, no. 8, p. 937-948 (2015)